ArticleTranslational andrology and urology2025
Development of a prognostic risk model for predicting biochemical recurrence-free survival in patients with prostate cancer based on lysine acetylation.
Bin Cao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.